Table 3.
Clinical outcomes in patients after stent deployment
| Technical success (n, %) | 30 (97) |
| Clinical success (n, %) | 27 (87) |
| GOOSS after procedure (n, %) | |
| Mean ± SD | 2.35 ± 0.91 |
| 0 (no oral intake) | 3 (10) |
| 1 (liquid diet) | 3 (10) |
| 2 (soft solid diet) | 7 (23) |
| 3 (low residue or normal diet) | 18 (58) |
| Improvement of GOOSS (mean ± SD) | 1.90 ± 0.94 |
| Procedure‐related adverse event | 3 (10) |
| Bleeding | 0 |
| Perforation | 1 (3) |
| Migration | 1 (3) |
| Cholangitis | 1 (3) |
| Pancreatitis | 0 |
| Additional chemotherapy | 11 (35) |
| Survival time, days (median, range) | 82 (30–341) |
| Stent dysfunction (total) (n, %) | 8 (30) |
| Stent in growth | 7 (26) |
| Stent overgrowth | 1 (4) |
| Stent migration | 0 |
| Stent kinking | 0 |
| Food impaction | 0 |
| Time to stent dysfunction (median, range) | 157 (11–183) |
| Additional stent deployment | 6 (75) |
Data are numbers; data in parentheses are percentages.
GOOSS, gastric outlet obstruction scoring system.